What is the purpose of the study?
We are conducting a PET (positron emission tomography) imaging study to help us understand opioid addiction. The goal of this study is to take pictures of a brain molecule named fatty acid amide hydrolase (FAAH). Knowing more about this enzyme molecule can help us assess risks and understand more about how opioid addiction is developed.
Who is needed?
- Individuals with: opioid use disorder, chronic pain, taking prescription opioids, (codeine, hydrocodone, oxycodone, morphine, etc.)
Age range: 18 -80
Gender: All
Ethnicity: All
What does the study involve?
- Number of contacts: 2-3 visits, 1 phone call
- Time period: 1 month
- Length of contacts: 12-13 hrs total for visits, 15 min. phone call
- Treatment offered: No
Study Location(s):
250 College St., Research Imaging Centre
Investigator(s): Dr. Isabelle Boileau, Dr. Bernard Le Foll
Contact Information:
- Phone: 416-535-8501 ext.33094
- E-mail: claire.shyu@camh.ca
- Recruitment Flyer Link
Study End Date: 31 May 2025
REB number: 175/2020
Full Study Title: Probing endocannabinoid tone in chronic pain patients with opioid use disorder: A PET study with [C-11]CURB
PLEASE NOTE:
- Research staff cannot give medical advice over the phone.
- If you have specific questions regarding your health care, please contact your family physician.
- We regret that not everyone screened for a study will be eligible to participate
- For more information about other treatment options for mental illness or addiction offered by CAMH, visit www.camh.ca or call 416-535-8501.